Package 49884-605-11

{"route": ["ORAL"], "spl_id": "1b224518-6e15-47d1-b1ee-b1e1d92f70ae", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["850087", "850091", "900156", "900164", "1098608", "1146690"], "spl_set_id": ["fb59c76a-9b6f-40ea-ac3a-58c3195c4377"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Endo USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (49884-605-01)", "package_ndc": "49884-605-01", "marketing_start_date": "20130118"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (49884-605-05)", "package_ndc": "49884-605-05", "marketing_start_date": "20130118"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (49884-605-11)", "package_ndc": "49884-605-11", "marketing_start_date": "20130118"}], "brand_name": "Lamotrigine Extended Release", "product_id": "49884-605_1b224518-6e15-47d1-b1ee-b1e1d92f70ae", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "49884-605", "generic_name": "lamotrigine extended release", "labeler_name": "Endo USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine Extended Release", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "300 mg/1"}], "application_number": "ANDA201791", "marketing_category": "ANDA", "marketing_start_date": "20130118", "listing_expiration_date": "20261231"}